A new physiological medium uncovers biochemical and cellular alterations in Lesch-Nyhan disease fibroblasts

被引:2
作者
Escudero-Ferruz, Paula [1 ,2 ]
Ontiveros, Neus [1 ,2 ]
Cano-Estrada, Claudia [1 ,2 ]
Sutcliffe, Diane J. [3 ]
Jinnah, H. A. [3 ,4 ,5 ]
Torres, Rosa J. [6 ,7 ]
Lopez, Jose M. [1 ,2 ]
机构
[1] Univ Autonoma Barcelona, Inst Neurociencies, Cerdanyola Del Valles 08193, Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Unitat Bioquim, Fac Med, Cerdanyola Del Valles 08193, Barcelona, Spain
[3] Emory Univ, Dept Neurol, Sch Med, 101 Woodruff Circle,6305 Woodruff Mem Bldg, Atlanta, GA 30322 USA
[4] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA
[5] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA
[6] Inst Salud Carlos III ISCIII, Ctr Biomed Network Res Rare Dis, Madrid 28029, Spain
[7] La Paz Univ Hosp Hlth Res Inst, Dept Biochem, IdiPaz, Madrid 28046, Spain
关键词
Purine nucleotides; Folic acid; Lesch-Nyhan disease; ZMP; AICAR; Plasmax; ACTIVATED PROTEIN-KINASE; 5-AMINO-4-IMIDAZOLECARBOXAMIDE RIBOSIDE; METABOLISM; BIOSYNTHESIS;
D O I
10.1186/s10020-023-00774-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundLesch-Nyhan disease (LND) is a severe neurological disorder caused by the genetic deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGprt), an enzyme involved in the salvage synthesis of purines. To compensate this deficiency, there is an acceleration of the de novo purine biosynthetic pathway. Most studies have failed to find any consistent abnormalities of purine nucleotides in cultured cells obtained from the patients. Recently, it has been shown that 5-aminoimidazole-4-carboxamide riboside 5MODIFIER LETTER PRIME-monophosphate (ZMP), an intermediate of the de novo pathway, accumulates in LND fibroblasts maintained with RPMI containing physiological levels (25 nM) of folic acid (FA), which strongly differs from FA levels of regular cell culture media (2200 nM). However, RPMI and other standard media contain non-physiological levels of many nutrients, having a great impact in cell metabolism that does not precisely recapitulate the in vivo behavior of cells.MethodsWe prepared a new culture medium containing physiological levels of all nutrients, including vitamins (Plasmax-PV), to study the potential alterations of LND fibroblasts that may have been masked by the usage of non-physiological media. We quantified ZMP accumulation under different culture conditions and evaluated the activity of two known ZMP-target proteins (AMPK and ADSL), the mRNA expression of the folate carrier SLC19A1, possible mitochondrial alterations and functional consequences in LND fibroblasts.ResultsLND fibroblasts maintained with Plasmax-PV show metabolic adaptations such a higher glycolytic capacity, increased expression of the folate carrier SCL19A1, and functional alterations such a decreased mitochondrial potential and reduced cell migration compared to controls. These alterations can be reverted with high levels of folic acid, suggesting that folic acid supplements might be a potential treatment for LND.ConclusionsA complete physiological cell culture medium reveals new alterations in Lesch-Nyhan disease. This work emphasizes the importance of using physiological cell culture conditions when studying a metabolic disorder.
引用
收藏
页数:20
相关论文
共 50 条
[41]   Neurocognitive functioning in Lesch-Nyhan disease and partial hypoxanthine-guanine phosphoribosyltransferase deficiency [J].
Schretlen, DJ ;
Harris, JC ;
Park, KS ;
Jinnah, HA ;
Del Pozo, NO .
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2001, 7 (07) :805-812
[42]   From genotype to phenotype; clinical variability in Lesch-Nyhan disease. The role of epigenetics [J].
Trigueros Genao, M. ;
Torres, R. J. .
REVISTA CLINICA ESPANOLA, 2014, 214 (08) :461-465
[43]   GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease [J].
Torres, Rosa J. ;
Puig, Juan G. .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (06) :1270-1276
[44]   Acute renal failure unmasking Lesch-Nyhan disease in a patient with tuberous sclerosis complex [J].
Thumfart, Julia ;
Weschke, Bernhard ;
Ringe, Hannelore ;
Weinhold, Natalie ;
Mueller, Dominik .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2016, 20 (04) :649-651
[45]   Very Early Levodopa May Prevent Self-Injury in Lesch-Nyhan Disease [J].
Visser, Jasper E. ;
Chorin, Odelia ;
Jinnah, H. A. .
PEDIATRIC NEUROLOGY, 2024, 155 :156-159
[46]   Altered membrane NTPase activity in Lesch-Nyhan disease fibroblasts: comparison with HPRT knockout mice and HPRT-deficient cell lines [J].
Pinto, CS ;
Jinnah, HA ;
Shirley, TL ;
Nyhan, WL ;
Seifert, R .
JOURNAL OF NEUROCHEMISTRY, 2005, 93 (06) :1579-1586
[47]   Antero-ventral internal pallidum stimulation improves behavioral disorders in Lesch-Nyhan disease [J].
Cif, Laura ;
Biolsi, Brigitte ;
Gavarini, Sophie ;
Saux, Aude ;
Robles, Santiago Gil ;
Tancu, Cornel ;
Vasques, Xavier ;
Coubes, Philippe .
MOVEMENT DISORDERS, 2007, 22 (14) :2126-2129
[48]   Multifocal atrophy of cerebellar internal granular neurons in Lesch-Nyhan disease: Case reports and review [J].
Del Bigio, Marc R. ;
Halliday, William C. .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2007, 66 (05) :346-353
[49]   Influence of age and strain on striatal dopamine loss in a genetic mouse model of Lesch-Nyhan disease [J].
Jinnah, HA ;
Jones, MD ;
Wojcik, BE ;
Rothstein, JD ;
Hess, EJ ;
Friedmann, T ;
Breese, GR .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (01) :225-229
[50]   Safety and Efficacy of Botulinum Toxin in the Treatment of Self-Biting Behavior in Lesch-Nyhan Disease [J].
del Mar Garcia-Romero, Maria ;
Torres, Rosa J. ;
Garcia-Puig, Juan ;
Ignacio Pascual-Pascual, Samuel .
PEDIATRIC NEUROLOGY, 2022, 127 :6-10